NASDAQ: SKYE · Life Sciences · 6 alerts · CIK 1516551
Share price
$1.07Close, Nov 16
Market cap
$4.71M
Shares outstanding
4.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Skye Bioscience, Inc. filings on SEC EDGAR ↗
Skye Bioscience Director Andrew J. Schwab Sells $230K of Stock
Andrew J. Schwab, Director, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $230K of Stock
5AM Partners VII LLC, 10% Owner, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
Skye Bioscience Director Andrew J. Schwab Sells $62.3K of Stock
Andrew J. Schwab, Director, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $62.3K of Stock
5AM Partners VII LLC, 10% Owner, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).